Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in First-line Treatment for Patients With Metastatic Lung Adenocarcinoma: A Randomized Phase III Study
Latest Information Update: 22 Nov 2024
At a glance
- Drugs Carboplatin (Primary) ; Pembrolizumab (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma; Bone metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms CRYOMUNE
Most Recent Events
- 19 Nov 2024 Planned End Date changed from 1 Aug 2025 to 27 Aug 2028.
- 19 Nov 2024 Planned primary completion date changed from 1 Aug 2023 to 27 Aug 2026.
- 29 Oct 2021 Planned number of patients changed from 126 to 214.